These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 26226970)
1. Pharmacology, Toxicology, and Adverse Effects of Synthetic Cannabinoid Drugs. Gurney SM; Scott KS; Kacinko SL; Presley BC; Logan BK Forensic Sci Rev; 2014 Jan; 26(1):53-78. PubMed ID: 26226970 [TBL] [Abstract][Full Text] [Related]
2. [Spice in France: mixed herbs containing synthetic cannabinoids]. Schlatter J; Chiadmi F; Chariot P Ann Biol Clin (Paris); 2012; 70(4):413-22. PubMed ID: 22796613 [TBL] [Abstract][Full Text] [Related]
3. Metabolism and toxicological analysis of synthetic cannabinoids in biological fluids and tissues. Presley BC; Gurney SM; Scott KS; Kacinko SL; Logan BK Forensic Sci Rev; 2016 Jul; 28(2):103-69. PubMed ID: 27257717 [TBL] [Abstract][Full Text] [Related]
4. [Spice drugs: cannabinoids as a new designer drugs]. Mustata C; Torrens M; Pardo R; Pérez C; ; Farré M Adicciones; 2009; 21(3):181-6. PubMed ID: 19718488 [TBL] [Abstract][Full Text] [Related]
5. Review of detection frequency and type of synthetic cannabinoids in herbal compounds analyzed by Istanbul Narcotic Department of the Council of Forensic Medicine, Turkey. Gurdal F; Asirdizer M; Aker RG; Korkut S; Gocer Y; Kucukibrahimoglu EE; Ince CH J Forensic Leg Med; 2013 Aug; 20(6):667-72. PubMed ID: 23910858 [TBL] [Abstract][Full Text] [Related]
6. Analysis of Synthetic Cannabinoids in Botanical Material: A Review of Analytical Methods and Findings. Presley BC; Jansen-Varnum SA; Logan BK Forensic Sci Rev; 2013 Mar; 25(1-2):27-46. PubMed ID: 26226849 [TBL] [Abstract][Full Text] [Related]
8. Cardiotoxicity associated with the synthetic cannabinoid, K9, with laboratory confirmation. Young AC; Schwarz E; Medina G; Obafemi A; Feng SY; Kane C; Kleinschmidt K Am J Emerg Med; 2012 Sep; 30(7):1320.e5-7. PubMed ID: 21802885 [TBL] [Abstract][Full Text] [Related]
9. Synthetic cannabinoid JWH-018 and psychosis: an explorative study. Every-Palmer S Drug Alcohol Depend; 2011 Sep; 117(2-3):152-7. PubMed ID: 21316162 [TBL] [Abstract][Full Text] [Related]
10. Clinical toxicology of newer recreational drugs. Hill SL; Thomas SH Clin Toxicol (Phila); 2011 Oct; 49(8):705-19. PubMed ID: 21970769 [TBL] [Abstract][Full Text] [Related]
11. Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings. Hermanns-Clausen M; Kneisel S; Szabo B; Auwärter V Addiction; 2013 Mar; 108(3):534-44. PubMed ID: 22971158 [TBL] [Abstract][Full Text] [Related]
12. [Synthetic cannabinoids--the new "legal high" drugs]. Berkovitz R; Arieli M; Marom E Harefuah; 2011 Dec; 150(12):884-7, 937. PubMed ID: 22352277 [TBL] [Abstract][Full Text] [Related]
13. A case of cannabinoid hyperemesis syndrome caused by synthetic cannabinoids. Hopkins CY; Gilchrist BL J Emerg Med; 2013 Oct; 45(4):544-6. PubMed ID: 23890687 [TBL] [Abstract][Full Text] [Related]
14. Effects of synthetic cannabinoids on electroencephalogram power spectra in rats. Uchiyama N; Kikura-Hanajiri R; Matsumoto N; Huang ZL; Goda Y; Urade Y Forensic Sci Int; 2012 Feb; 215(1-3):179-83. PubMed ID: 21640532 [TBL] [Abstract][Full Text] [Related]
15. Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013-2016: A Review. Logan BK; Mohr ALA; Friscia M; Krotulski AJ; Papsun DM; Kacinko SL; Ropero-Miller JD; Huestis MA J Anal Toxicol; 2017 Sep; 41(7):573-610. PubMed ID: 28459969 [TBL] [Abstract][Full Text] [Related]
16. [Pharmacological properties and dependence liabilities of synthetic cannabinoids]. Funada M Nihon Arukoru Yakubutsu Igakkai Zasshi; 2010 Jun; 45(3):167-74. PubMed ID: 20681249 [TBL] [Abstract][Full Text] [Related]
17. A structure-reactivity relationship driven approach to the identification of a color test protocol for the presumptive indication of synthetic cannabimimetic drugs of abuse. Isaacs RCA Forensic Sci Int; 2014 Sep; 242():135-141. PubMed ID: 25062530 [TBL] [Abstract][Full Text] [Related]
18. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
19. Role of lipids and lipid signaling in the development of cannabinoid tolerance. Martin BR Life Sci; 2005 Aug; 77(14):1543-58. PubMed ID: 15949820 [TBL] [Abstract][Full Text] [Related]
20. Designer drugs. Patients may be using synthetic cannabinoids more than you think. Lisi DM JEMS; 2014 Sep; 39(9):56-9. PubMed ID: 25322519 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]